The Valley Desk

PreprintSSRNPublished

A Phase I, Prospective, Randomized, Open-Labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source

Publication record

Type
Preprint
Venue
SSRN
Published
Added to directory
Source checked

Report a correction or request removal